Summary for Patients: Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease

Affiliations:

From: Schechter M, Jongs N, Chertow GM, et al. Effects of dapagliflozin on hospitalizations in patients with chronic kidney disease. A post hoc analysis of DAPA-CKD. Ann Intern Med. 6 December 2022. [Epub ahead of print]. doi:10.7326/M22-2115

Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.

Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.

This article was published at Annals.org on 6 December 2022.

留言 (0)

沒有登入
gif